What You Should Know:
- Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.
- AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications.
Automating the IND Process: A Game-Changer for Drug
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
PathAI Unveils New AI-Powered Pathology Tools for Cancer Research
What You Should Know:
- PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights.
- The product pairing provides unprecedented single-cell and spatial resolution of
Read More
New AI Test Aims to Improve Breast Cancer Recurrence Prediction: COTA, PreciseDx, and Baptist Health South Florida Collaborate
What You Should Know:
- A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for faster, more accurate, and more affordable risk prediction compared to current methods.
- By utilizing AI technology, PreciseBreast™ has the potential to offer patients a faster, more accurate, and more affordable way to assess their risk of
Read More
3 Steps to Unlock the True Potential of AI for Health Leaders
The AI buzz is not subsiding, making headlines across industries. In his summary article about the 2024 HIMSS conference, Chilmark Research’s John Moore III noted, “Good luck trying to get noticed for anything other than AI or cybersecurity (in the wake of the Change Healthcare breach).” One of Moore’s key takeaways was the consensus among attendees that while all the new AI use cases may be compelling, there is still concern about their readiness for broader deployment.
Yet, AI is
Read More
AI’s Transformative Power in Health, Wellness, and Supplements
The integration of Artificial Intelligence (AI) technologies into various sectors has been a game-changer, and the health and wellness industry is no exception. As we progress further into the digital age, AI is poised to revolutionize the way we approach our well-being, offering unprecedented opportunities for personalized care, predictive analytics, and targeted solutions.
AI in Healthcare: Revolutionizing Patient Care
In the realm of healthcare, AI has already made significant strides
Read More
Providence, Microsoft, UW Develop AI-Powered Pathology Model
What You Should Know:
- A collaborative effort between Providence, Microsoft, and the University of Washington has yielded a breakthrough in cancer diagnostics with the development of an AI-powered pathology model, Prov-GigaPath.
- Prov-GigaPath is an AI-powered pathology model designed to improve patient care and transform cancer diagnostics. It analyzes entire pathology slides to identify patterns, leading to more accurate mutation predictions and effective cancer subtyping. The
Read More
Atropos Health Raises $33M to Improve Value-Based Care Through Real-World Evidence
What You Should Know:
- Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care, today announced a $33 million Series B on the heels of the adoption of its Generative AI platform (GENEVA OSTM) by healthcare institutions, data platforms, research institutions, Life Sciences companies and more.
- The funding was led by Valtruis, with participation from new strategic investors
Read More
Tempus AI Files for IPO, Eyes Over $600M in Funding for AI-Powered Precision Medicine
What You Should Know:
- Tempus AI, a leader in artificial intelligence (AI)-powered precision medicine, filed with the Securities and Exchange Commission (SEC) on Monday to raise up to $100M in an initial public offering (IPO). Industry analysts, however, believe this figure might be a placeholder, with the actual target amount closer to $600M.
- Founded in 2015 and headquartered in Chicago, Illinois, Tempus AI reported $562M in revenue for the fiscal year ending March 31,
Read More
Twin Health Unveils Digital Twin AI for Weight Loss with GLP-1 Elimination
What You Should Know:
- Today, Twin Health announced it is extending its whole body digital twin AI platform, proven to help members achieve remission of type 2 diabetes and eliminate medications, to address the challenge of obesity and weight loss.
- Twin’s Healthy Weight solution combines digital twin AI and compassionate clinical care to help members achieve a healthy weight that they can sustain
Read More
SPRY Launches AI-Integrated EMR for Rehab Therapy
What You Should Know:
- SPRY Therapeutics (“SPRY”), creator of rehab therapy’s first fully integrated, AI-powered EMR, today announced the introduction of SPRY Ally, a suite of AI-powered tools for rehab therapy.
- The tools leverage AI’s ability to continually learn as it dramatically improves the efficiency and accuracy of clinical
Read More
